马上注册,结交更多好友,享用更多功能,让你轻松玩转社区。
您需要 登录 才可以下载或查看,没有账号?立即注册
x
《Hydrogen gas activates coenzyme Q10 to restore exhausted CD8+ T cells, especially PD-1+Tim3+terminal CD8+ T cells, leading to better nivolumab outcomes in patients with lung cancer》
7 n1 @4 A8 |6 f7 ]' C / d0 }- `" Y8 \4 b+ J5 c1 o
这是日本的一个O药联合或者不联合吸氢气治疗非小细胞肺癌的前瞻性随机对照试验。7 _ ~, t4 P1 R9 G
3 N2 J* J4 c# t2 M: A0 i- \1 X5 s
制氢机出气量等情况是这样:“The Hycellvator ET 100 (Helix Japan, Co., Ltd.) generates 1.67 l/ min hydrogen gas (hydrogen purity, 99.99%) by electrolysis. As measured by gas chromatography at Kureha Special Laboratory, the gas generated 680,000 ppm hydrogen gas and 320,000 ppm oxygen gas. Recently, hydrogen gas inhalation was used in patients with post-cardiac arrest syndrome, and adverse events were not observed”3 u4 a; {* h3 A, d
7 O1 W" `6 T! L r' e
患者每天吸三个小时氢气。 k5 \ i1 g+ ?; q: F+ b; C6 {7 h
) M/ i( V4 j! l, p1 }60个月的随访,临床试验结果是:“Kaplan-Meyer analysis showed that the HGN-treated patients had a significantly longer OS than those treated with NO (Fig. 1A). Median survival time (MST) for the HGN-treated patients was 28 months, a length that is approximately 3-fold longer than that for NO-treated patients (MST 9 months) (Fig. 1A).”* T! R% c' c& R$ b7 E+ w0 o5 j
% ~$ n: ]1 }* @4 Y! `
联合吸氢组的中位生存期是28月,不联合吸氢组的中位生存期是9个月。. V: N$ r" t8 L" o; ~ n" }7 b
# v& i3 a& ~+ y3 w研究者认为联合吸氢组疗效更好的原因是 “Hydrogen gas activates coenzyme Q10 to restore exhausted CD8+ T cells, especially PD-1+Tim3+terminal CD8+ T cells。”1 Z1 |) p- q, H0 [2 i8 |# V$ ]
/ h/ w" D& [& u% N1 m
研究者在临床试验基线和过程中检测了入组患者的血液辅酶Q10的含量极其变化。8 D% q- N5 f4 S: R
7 f$ I" }* o2 U( Z, A
“We measured the CoQ10 concentration in the 35 HGN-treated patients with stage IV lung cancer and investigated its association with OS. The cut-off value was found to be 0.985 µg/ml (ROC curve; AUC=0.803, Sensitivity=83.3%, Specificity=81.8%, (Fig. 2E). Further, the 35 HGN-treated patients were stratified as having high (>0.985 µg/ml) and low (<0.985 µg/ml) CoQ10 concentrations. There were no significant differences in the clinico-pathological factors between patients with high and low CoQ10 (Table III). Patients with high CoQ10 had a significantly longer OS than those with low CoQ10 (Fig. 2F). MST of patients with high CoQ10 was 25 months, while that of patients with low CoQ10 was 8 months (Fig. 2F).”
* g' x% y. t1 [+ q4 W
2 R+ I, ^- D2 V: A5 l" w“Following hydrogen gas treatment, the concentration of CoQ10 was increased in 19 (46%) of 41 patients (Table IV). Hence, we proceeded to calculate the rate of change of CoQ10 by hydrogen gas treatment (CoQ10 ratio=CoQ10 concentration after treatment/CoQ10 concentration before treatment) and classified patients by high- and low-CoQ10 ratio using the cut-off value (1.175) (ROC curve; AUC=0.710, Sensitivity=75.0%, Specificity=66.7%) (Fig. 2G). Patients with a high-CoQ10 ratio survived significantly longer than those with a low-CoQ10 ratio, as shown in Fig. 2H. MST of patients with a high CoQ10 ratio was NR (not reached to 50% overall survival), while that of patients with low CoQ10 was 9 months (Fig. 2H).”
% T7 b) j# |- S: {
0 ^: ]% w' X% k7 B( _血液辅酶Q10浓度高的患者,用icb的OS更长。
2 w8 z% t' o, r& S: ~$ @: A2 b |